Home › Kanser sa Larynx
Pag-aaral pangklinika para sa Kanser sa Larynx na nagre-recruit sa U.S.
26 pag-aaral para sa Kanser sa Larynx ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Chicago, IL8 pag-aaral
- Milwaukee, WI8 pag-aaral
- Atlanta, GA8 pag-aaral
- Kansas City, MO7 pag-aaral
- St. Louis, MO7 pag-aaral
- Edison, NJ6 pag-aaral
- Baltimore, MD6 pag-aaral
- Richmond, VA6 pag-aaral
- Cincinnati, OH6 pag-aaral
- Pittsburgh, PA6 pag-aaral
- Durham, NC6 pag-aaral
- Portland, OR6 pag-aaral
- Kansas City, KS5 pag-aaral
- Overland Park, KS5 pag-aaral
- Cape Girardeau, MO5 pag-aaral
- Oklahoma City, OK5 pag-aaral
- Cedar Rapids, IA5 pag-aaral
- Peoria, IL5 pag-aaral
- Duluth, MN5 pag-aaral
- Lansing, MI5 pag-aaral
- Danville, IL5 pag-aaral
- Champaign, IL5 pag-aaral
- Stevens Point, WI5 pag-aaral
- Wausau, WI5 pag-aaral
- Naperville, IL5 pag-aaral
- Joliet, IL5 pag-aaral
- Bloomington, IL5 pag-aaral
- Charleston, IL5 pag-aaral
- Ann Arbor, MI5 pag-aaral
- Omaha, NE5 pag-aaral
- Philadelphia, PA5 pag-aaral
- Fargo, ND5 pag-aaral
- New York City, NY5 pag-aaral
- Queens, NY5 pag-aaral
- Irvine, CA5 pag-aaral
- Tampa, FL4 pag-aaral
- Boston, MA4 pag-aaral
- Aurora, IL4 pag-aaral
- Cicero, IL4 pag-aaral
- Erie, PA4 pag-aaral
Ayos sa estado
- Arizona5 pag-aaral
- Arkansas5 pag-aaral
- California9 pag-aaral
- Colorado7 pag-aaral
- Connecticut3 pag-aaral
- Delaware3 pag-aaral
- Florida8 pag-aaral
- Georgia8 pag-aaral
- Idaho4 pag-aaral
- Illinois9 pag-aaral
- Indiana4 pag-aaral
- Iowa8 pag-aaral
- Kansas7 pag-aaral
- Kentucky3 pag-aaral
- Louisiana4 pag-aaral
- Maryland7 pag-aaral
- Massachusetts7 pag-aaral
- Michigan6 pag-aaral
- Minnesota7 pag-aaral
- Mississippi3 pag-aaral
- Missouri9 pag-aaral
- Montana5 pag-aaral
- Nebraska5 pag-aaral
- New Hampshire3 pag-aaral
- New Jersey7 pag-aaral
- New Mexico3 pag-aaral
- New York10 pag-aaral
- North Carolina8 pag-aaral
- North Dakota5 pag-aaral
- Ohio11 pag-aaral
- Oklahoma6 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania9 pag-aaral
- South Carolina5 pag-aaral
- South Dakota3 pag-aaral
- Tennessee3 pag-aaral
- Texas5 pag-aaral
- Virginia7 pag-aaral
- Washington3 pag-aaral
- Wisconsin9 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06589804Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07195734Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06980038BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05136196Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07441681Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT01365169Integrated Cancer Repository for Cancer Research
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 11, 2026 · NCT06997068Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT07209189Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 11, 2026 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT01473784CONFIRM: Magnetic Resonance Guided Radiation Therapy
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT04368702Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT05793151Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 26, 2025 · NCT06080503SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2025 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Nagre-recruitObservasyonal na pag-aaral
Edad 21 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2025 · NCT00900419Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.